The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements. .
Urs Wiedemann
Advertisement
Articles by Urs Wiedemann
Advertisement
Latest Updated Articles
Raising the Stakes On Value-Based PricingPublished: April 12th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions
5
